Page 17 - 《中国药房》2024年8期
P. 17

nel”  management  policies  of  nationally  negotiated  drugs   模式研究[J]. 世界临床药物,2021,42(9):734-740.
              in Jiangsu Province[J]. Chin J Health Policy,2022,15(7):  LI Y,DING  J  X,LI W,et  al.  Research  on  the  infusion
              38-44.                                              management model of national reimbursement negotiation
          [ 5 ]  付瑞枫,茅宁莹. “双通道” 背景下国谈创新药零售终端                      drugs  under “dual  channel”  management  mechanism[J].
              流通现状[J]. 卫生经济研究,2023,40(2):24-27,33.                World Clin Drugs,2021,42(9):734-740.
              FU  R  F,MAO  N  Y.  Analysis  on  the  circulation  and          [13]  韩晓睿,丁锦希,李伟,等. 国家谈判药品“双通道” 的遴
              obstacles of innovative drugs in retail terminal under the   选标准与实施路径[J]. 世界临床药物,2021,42(9):
              dual-channel policy in China[J]. Health Econ Res,2023,  717-724.
              40(2):24-27,33.                                     HAN X R,DING J X,LI W,et al. Research on the selec‐
          [ 6 ]  SMITH  T  B.  The  policy  implementation  process[J].   tion  criteria  and  implementation  path  of “dual  channel”
              Policy Sci,1973,4(2):197-209.                       management mechanism for national reimbursement nego‐
          [ 7 ]  陈庆云 . 公共政策分析[M]. 北京:北京大学出版社,                     tiation drugs[J]. World Clin Drugs,2021,42(9):717-724.
              2006:169.                                      [14]  刘心怡,张璐莹,陈文. 国家谈判药品的医保管理实践案
              CHEN  Q  Y.  Public  policy  analysis[M].  Beijing:Peking   例研究[J]. 中国医疗保险,2021(3):34-37.
              University Press,2006:169.                          LIU  X Y,ZHANG  L Y,CHEN  W.  Case  studies  on  the
          [ 8 ]  朱文静,褚福浩. 药品“双通道” 机制下定点零售药店执                      medical  insurance  management  of  national  negotiated
              业药师作用探讨[J]. 中国药业,2023,32(20):17-20.                 drugs in China[J]. China Health Insur,2021(3):34-37.
              ZHU W J,CHU F H. Discussion on the role of licensed   [15]  高学坤,孙言才,虞德才,等. 某三甲专科医院药品冷链
              pharmacists  in  designated  retail  drugstores  under  the   自动监控管理系统的建设实践[J]. 中国药房,2018,29
              “dual  channel”  mechanism  of  drugs[J].  China  Pharm,  (17):2323-2327.
              2023,32(20):17-20.                                  GAO X K,SUN Y C,YU D C,et al. Construction of drug
          [ 9 ]  彭瑾,蒋俊男,邱增辉,等. 国家医保谈判药品在浙江省                       cold chain automatic monitoring management system in a
              三级医疗机构的落地实践[J]. 中国药房,2023,34(10):                   third grade class A special hospital[J]. China Pharm,2018,
              1159-1164.                                          29(17):2323-2327.
              PENG J,JIANG J N,QIU Z H,et al. Landing practices of   [16]  杨赐然,王瑞,罗银,等. 国谈药“双通道” 管理政策设计
              national  medical  insurance  negotiated  drugs  in  tertiary   的省际比较研究[J]. 中国卫生政策研究,2023,16(4):
              medical  institutions  of  Zhejiang  Province[J].  China   25-31.
              Pharm,2023,34(10):1159-1164.                        YANG  C  R,WANG  R,LUO  Y,et  al.  Inter-provincial
          [10]  张博,丁锦希,陈烨,等. 国家医保谈判药品“双通道” 政                      comparative  study  on  the  design  of “dual-channel”  ma-
              策动因与实施模式[J]. 世界临床药物,2021,42(9):                     nagement policies for national health insurance negotiated
              709-716.                                            drugs[J]. Chin J Health Policy,2023,16(4):25-31.
              ZHANG B,DING J X,CHEN Y,et al. Research on the   [17]  南京市医疗保障局 . 线上开方 统一流转 便捷购药! 南
              policy  motivation  and  implementation  model  of “dual   京市医保电子处方流转超 3 万人次[EB/OL].(2023-08-
              channel” management mechanism for national reimburse‐  17)[2023-11-03].  http://ybj. nanjing. gov. cn/gzdt/202308/
              ment  negotiation  drugs[J].  World  Clin  Drugs,2021,42  t20230817_3989143.html.
              (9):709-716.                                        Nanjing  Healthcare  Security Administration.  Online  pre‐
          [11]  国家药品监督局药品评价中心,国家药品不良反应监测                          scription  and  unified  circulation  for  convenient  medicine
              中心 . 国家药品不良反应监测年度报告:2022 年[J]. 中                    purchase!  The  circulation  of  electronic  prescriptions  for
              国药物警戒,2023,20(6):712-719.                           medical insurance in Nanjing has exceeded 30 000 person-
              Center for Drug Reevaluation of NMPA,National Center   times[EB/OL].(2023-08-17)[2023-11-03]. http://ybj.nanjing.
              for ADR Monitoring of China. National adverse drug reac‐  gov.cn/gzdt/202308/t20230817_3989143.html.
              tion monitoring annual report:2022[J]. Chin J Pharmaco‐       (收稿日期:2023-10-18  修回日期:2024-03-21)
              vigil,2023,20(6):712-719.                                                           (编辑:孙 冰)
          [12]  李轶,丁锦希,李伟,等. “双通道” 谈判药品的输注管理






          中国药房  2024年第35卷第8期                                                 China Pharmacy  2024 Vol. 35  No. 8    · 911 ·
   12   13   14   15   16   17   18   19   20   21   22